InAKTivation of insulin/IGF-1 signaling by dephosphorylation

被引:17
|
作者
Narasimhan, Sri Devi [1 ]
Mukhopadhyay, Arnab [2 ]
Tissenbaum, Heidi A. [1 ,3 ]
机构
[1] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA
[2] Natl Inst Immunol, New Delhi 110067, India
[3] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA
关键词
phosphorylation; PP2A; B56; Akt; insulin/IGF-1; signaling; FOXO; lifespan; metabolism; C; elegans; DAF-16; PROTEIN PHOSPHATASE 2A; FOXO TRANSCRIPTION FACTORS; C-ELEGANS DAF-16; AGE-1; PI3; KINASE; LIFE-SPAN; CAENORHABDITIS-ELEGANS; TUMOR-SUPPRESSOR; REGULATES LONGEVITY; AKT; PATHWAY;
D O I
10.4161/cc.8.23.10072
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Signal transduction pathways are tightly regulated by phosphorylation-dephosphorylation cycles and yet the mammalian genome contains far more genes that encode for protein kinases than protein phosphatases. Therefore, to target specific substrates, many phosphatases associate with distinct regulatory subunits and thereby modulate multiple cellular processes. One such example is the C. elegans PP2A regulatory subunit PPTR-1 that negatively regulates the insulin/insulin-like growth factor signaling pathway to modulate longevity, dauer diapause, fat metabolism and stress resistance. PPTR-1, as well as its mammalian homolog B56 beta, specifically target the PP2A enzyme to AKT and mediate the dephosphorylation of this important kinase at a conserved threonine residue. In C. elegans, the major consequence of this modulation is activation of the FOXO transcription factor homolog DAF-16, which in turn regulates transcription of its many target genes involved in longevity and stress resistance. Understanding the function of B56 subunits may have important consequences in diseases such as Type 2 diabetes and cancer where the balance of Akt phosphorylation is deregulated.
引用
收藏
页码:3878 / 3884
页数:7
相关论文
共 50 条
  • [1] The role of insulin and IGF-1 signaling in longevity
    M. Katic
    C. R. Kahn
    Cellular and Molecular Life Sciences CMLS, 2005, 62 : 320 - 343
  • [2] IGF-1 and insulin signaling in the control of longevity
    Bartke, A
    Kopchick, J
    Dominici, F
    Turyn, D
    ENDOCRINE ASPECTS OF SUCCESSFUL AGING: GENES, HORMONES AND LIFESTYTLES, 2004, : 19 - 33
  • [3] The role of insulin and IGF-1 signaling in longevity
    Katic, M
    Kahn, CR
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (03) : 320 - 343
  • [4] The paradox of the insulin/IGF-1 signaling pathway in longevity
    Rincon, M
    Muzumdar, R
    Atzmon, G
    Barzilai, N
    MECHANISMS OF AGEING AND DEVELOPMENT, 2004, 125 (06) : 397 - 403
  • [5] Effects of insulin glulisine on the insulin and IGF-1 receptor signaling cascades
    Seipke, G
    Stammberger, I
    DIABETES, 2005, 54 : A339 - A340
  • [6] The role of insulin/IGF-1 signaling pathway in aging and cancer
    Anisimov, VN
    FRONTIERS IN NEURODEGENERATIVE DISORDERS AND AGING: FUNDAMENTAL ASPECTS, CLINICAL PERSPECTIVES AND NEW INSIGHTS, 2004, 358 : 56 - 73
  • [7] Temporal requirements of insulin/IGF-1 signaling for proteotoxicity protection
    Cohen, Ehud
    Du, Deguo
    Joyce, Derek
    Kapernick, Erik A.
    Volovik, Yuli
    Kelly, Jeffery W.
    Dillin, Andrew
    AGING CELL, 2010, 9 (02): : 126 - 134
  • [8] Genetic variation in insulin/IGF-1 signaling pathways and longevity
    Ziv, Elad
    Hu, Donglei
    AGEING RESEARCH REVIEWS, 2011, 10 (02) : 201 - 204
  • [9] MOLECULAR DEFECTS OF INSULIN IGF-1 RECEPTOR TRANSMEMBRANE SIGNALING
    FRATTALI, AL
    PESSIN, JE
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 687 : 77 - 89
  • [10] Insulin, IGF-1 and longevity
    van Heemst, Diana
    AGING AND DISEASE, 2010, 1 (02): : 147 - 157